The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020
- PMID: 20214473
- DOI: 10.1086/652237
The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020
Abstract
The time has come for a global commitment to develop new antibacterial drugs. Current data document the impending disaster due to the confluence of decreasing investment in antibacterial drug research and development concomitant with the documented rapid increase in the level of resistance to currently licensed drugs. Despite the good faith efforts of many individuals, professional societies, and governmental agencies, the looming crisis has only worsened over the past decade.
Comment in
-
Questions about the 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):751-2; author reply 754-5. doi: 10.1086/655955. Clin Infect Dis. 2010. PMID: 20731566 No abstract available.
-
Development of new antibacterials: a laudable aim, but what is the value?Clin Infect Dis. 2010 Sep 15;51(6):752-3; author reply 754-5. doi: 10.1086/655956. Clin Infect Dis. 2010. PMID: 20731567 No abstract available.
-
Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):753; author reply 754-5. doi: 10.1086/655957. Clin Infect Dis. 2010. PMID: 20731568 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
